(Q81208127)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18454174%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

title

Overexpression of mRNA-binding protein CRD-BP in malignant melanomas (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18454174%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

author name string

I Elcheva

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18454174%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

R S Tarapore

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18454174%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

N Bhatia

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18454174%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

V S Spiegelman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18454174%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

publication date

5 May 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18454174%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18454174%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18454174%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

issue

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18454174%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

page(s)

5069-5074

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18454174%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/onc.2008.141

6 January 2020

exact match

0 references

cites work

Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.141

Mouse homologue of HOS (mHOS) is overexpressed in skin tumors and implicated in constitutive activation of NF-kappaB

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.141

Malignant melanoma: genetics and therapeutics in the genomic era.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.141

Expression of oncofetal RNA-binding protein CRD-BP/IMP1 predicts clinical outcome in colon cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.141

The c-myc coding region determinant-binding protein: a member of a family of KH domain RNA-binding proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.141

The many faces of beta-TrCP E3 ubiquitin ligases: reflections in the magic mirror of cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.141

Introduction to NF-kappaB: players, pathways, perspectives

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.141

Molecular targets in melanoma: strategies and challenges for diagnosis and therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.141

Apoptosis and melanoma: molecular mechanisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.141

C‐MYC and IGF‐II mRNA‐binding protein (CRD‐BP/IMP‐1) in benign and malignant mesenchymal tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.141

Oncogenic BRAF regulates beta-Trcp expression and NF-kappaB activity in human melanoma cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.141

A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.141

CRD-BP mediates stabilization of betaTrCP1 and c-myc mRNA in response to beta-catenin signalling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.141

Frequent nuclear/cytoplasmic localization of beta-catenin without exon 3 mutations in malignant melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.141

Overexpression of an mRNA-binding protein in human colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.141

Stabilization of beta-catenin by genetic defects in melanoma cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.141

H19 RNA binds four molecules of insulin-like growth factor II mRNA-binding protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.141

Loitering with intent: new evidence for the role of BRAF mutations in the proliferation of melanocytic lesions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.141

CRD-BP shields c-myc and MDR-1 RNA from endonucleolytic attack by a mammalian endoribonuclease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.141

Wnt/beta-catenin signaling induces the expression and activity of betaTrCP ubiquitin ligase receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.141

Induction of homologue of Slimb ubiquitin ligase receptor by mitogen signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.141

NF-kappaB activation in melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.141

RNA-binding IMPs promote cell adhesion and invadopodia formation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.141

c-Myc depletion inhibits proliferation of human tumor cells at various stages of the cell cycle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.141

A Wnt-er wonderland--the complexity of Wnt signaling in melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.141